| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
225,105 |
176,029 |
$13.85M |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
159,094 |
121,772 |
$2.93M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,963 |
2,761 |
$959K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,164 |
5,435 |
$657K |
| 88364 |
|
3,265 |
3,237 |
$595K |
| 87507 |
|
1,467 |
1,449 |
$423K |
| 87150 |
|
8,492 |
6,445 |
$357K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
7,217 |
5,393 |
$294K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
8,526 |
6,973 |
$259K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
6,759 |
5,720 |
$204K |
| 88365 |
|
3,274 |
3,248 |
$200K |
| 87581 |
|
8,031 |
6,300 |
$123K |
| 87506 |
|
2,671 |
2,112 |
$95K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
173 |
164 |
$65K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,361 |
3,054 |
$63K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,008 |
2,210 |
$61K |
| 88342 |
|
2,385 |
2,149 |
$54K |
| 87486 |
|
8,166 |
6,437 |
$54K |
| 88313 |
|
3,574 |
3,244 |
$54K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
6,923 |
4,838 |
$54K |
| 83520 |
|
6,914 |
4,804 |
$46K |
| 87634 |
|
4,212 |
3,056 |
$44K |
| 87631 |
|
1,450 |
923 |
$35K |
| 87541 |
|
5,074 |
3,474 |
$31K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
9,754 |
6,896 |
$27K |
| 87496 |
|
3,955 |
2,808 |
$24K |
| 87532 |
|
3,889 |
2,744 |
$19K |
| 87503 |
|
4,282 |
3,020 |
$19K |
| 87498 |
|
3,891 |
2,744 |
$17K |
| 83631 |
|
6,018 |
4,931 |
$15K |
| 88312 |
|
1,582 |
1,326 |
$14K |
| 83993 |
|
5,491 |
4,796 |
$12K |
| 86769 |
|
491 |
265 |
$12K |
| 87209 |
|
5,168 |
4,238 |
$11K |
| 82656 |
|
6,222 |
5,124 |
$9K |
| 87338 |
|
5,382 |
4,181 |
$9K |
| 82657 |
|
1,741 |
839 |
$9K |
| 82274 |
|
5,851 |
4,639 |
$7K |
| 87177 |
|
5,219 |
4,286 |
$6K |
| 87500 |
|
1,206 |
778 |
$5K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
146 |
143 |
$4K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
74 |
72 |
$3K |
| 87324 |
|
552 |
454 |
$2K |
| 82705 |
|
4,785 |
3,829 |
$2K |
| 89055 |
|
2,987 |
2,429 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
25 |
22 |
$2K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
721 |
517 |
$1K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
74 |
72 |
$1K |
| 87481 |
|
56 |
44 |
$1K |
| 87640 |
|
248 |
239 |
$1K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
55 |
53 |
$808.73 |
| 87529 |
|
16 |
15 |
$608.00 |
| 88142 |
|
27 |
27 |
$604.04 |
| 87641 |
|
399 |
266 |
$603.74 |
| 0097U |
|
48 |
48 |
$304.96 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
28 |
28 |
$263.09 |
| 87511 |
|
14 |
14 |
$190.00 |
| 87653 |
|
33 |
31 |
$173.30 |
| 87505 |
|
18 |
13 |
$83.80 |
| 80053 |
Comprehensive metabolic panel |
58 |
54 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
107 |
92 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
13 |
12 |
$0.00 |
| 86140 |
|
12 |
12 |
$0.00 |
| 80061 |
Lipid panel |
15 |
13 |
$0.00 |